In 2025, Johnson & Johnson’s net earnings were estimated to be about billion U.S. dollars. There was a two-fold increase in net earnings in comparison to the previous year.
Johnson & Johnson’s revenue overview
Johnson & Johnson is a U.S.-based multinational company that is headquartered in New Brunswick, New Jersey, in the United States. The company’s largest business segment is its pharmaceutical segment, but the company also operates in medical devices and diagnostics. Regionally, the United States is responsible for the largest proportion of Johnson & Johnson’s sales, followed by Europe.
Johnson & Johnson’s global R&D positioning
Johnson & Johnson has been ranked second among global pharmaceutical companies based on the dollar amount spent on research and development in 2023. Johnson & Johnson is ranked among the major pharmaceutical companies based on the number of original drugs. Similarly, Johnson & Johnson is ranked among the top seven pharmaceutical companies based on the number of drugs in development as of 2025.
We’re happy to help
Get in touch with us for additional information
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.